Merida Therapeutics has launched with a $121 million Series A funding round co-led by Third Rock Ventures and Bain Capital Life Sciences. This funding will support the company's development of Fc-based therapeutics for autoimmune disorders.
Amount Raised
$121 Million
Round Type
Series A
CambridgeBiotechnologyHealth CareTherapeuticsInvestors
Description
Merida Therapeutics has officially unveiled its drug development platform and secured $121 million in Series A financing. Third Rock Ventures co-led the round alongside Bain Capital Life Sciences and other notable investors. The funds will be used to advance their protein engineering platform aimed at treating autoimmune diseases like Graves' disease. The lead program is focused on precision therapeutics targeting pathogenic antibodies.
Quick answer
Merida Therapeutics raised $121 Million in a Series A round, dated April 8, 2025. Investors: Perceptive Xontogeny Venture Funds, Bain Capital Life Sciences, BVF Partners, GV and Third Rock Ventures. Merida Therapeutics is based in Cambridge, Massachusetts, United States.
- How much did Merida Therapeutics raise?
- Merida Therapeutics raised $121 Million in a Series A round on April 8, 2025.
- Who invested in Merida Therapeutics?
- Perceptive Xontogeny Venture Funds, Bain Capital Life Sciences, BVF Partners, GV and Third Rock Ventures are named as investors in this round.
- What does Merida Therapeutics do?
- Merida is advancing a precision immunology approach for antibody-driven diseases that selectively and durably eliminate their pathogenic drivers.
- Where is Merida Therapeutics based and how big is it?
- Merida Therapeutics is based in Cambridge, Massachusetts, United States.
- Who are the decision-makers at Merida Therapeutics?
- Fundz holds 1 contact at Merida Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Merida Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Entos Pharmaceuticals raised an undisclosed amount (Funding Round) on May 22, 2025.
- VolitionRx raised $16M on May 20, 2025.
- Massalia Therapeutics raised an undisclosed amount (Seed) on May 20, 2025.
- Cellestial Health raised an undisclosed amount (Pre-Seed) on May 9, 2025.
- ImmuneWalk Therapeutics raised $7M (Seed) on May 8, 2025.
- Avammune Therapeutics raised $12M (Series A) on May 7, 2025.
Who to call at Merida Therapeutics, and when
A new round usually means Merida Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Merida Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Merida Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Merida Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Merida Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansMerida Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.